Evidence map›Paper›PMID 23819467›Full record

ArticleBMC medical genomics2013

BioBin: a bioinformatics tool for automating the binning of rare variants using publicly available biological knowledge.

Carrie B Moore, John R Wallace, Alex T Frase, Sarah A Pendergrass, Marylyn D Ritchie

Abstract read
In one paragraph

Article in BMC medical genomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genetic Analysis of Functional Rare Germline Variants across Nine Cancer Types from an Electronic Health Record Linked Biobank.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Codon bias among synonymous rare variants is associated with Alzheimer's disease imaging biomarker.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carrie B MooreCenter for Human Genetics Research, Vanderbilt University, Nashville, TN 37232, USA.
John R Wallace
Alex T Frase
Sarah A Pendergrass
Marylyn D Ritchie

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
PHARMACOGENOMICS OF ARRHYTHMIA THERAPYU01HL065962 · NHLBI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2001 to 2009
$24.8M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
Next Generation Mendelian GeneticsRC2HG005608 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2009 to 2010
$3.9M
Genome-Wide Study of Cataract and Low HDL in the Personalized Medicine Research PU01HG004608 · NHGRI · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI MCCARTY, CATHERINE ANNE · 2007 to 2010
$3.3M
Training Program on Genetic Variation and Human PhenotypesT32GM080178 · NIGMS · VANDERBILT UNIVERSITY · PI COX, NANCY J, SAMUELS, DAVID C · 2007 to 2021
$3.1M
Analysis Tool for Heritable and Envirnonmental Network AssociationsR01LM010040 · NLM · VANDERBILT UNIVERSITY · PI RITCHIE, MARYLYN D · 2009 to 2010
$1.9M
A Biologically Informed Method for Detecting Associations with Rare VariantsF30AG041570 · NIA · VANDERBILT UNIVERSITY · PI MOORE, CARRIE COLLEEN BUCHANAN · 2011 to 2014
$149k
GENOMEWIDE ANALYSIS OF INTERACTIONS IN ALZHEIMER DISEASE USING NEURAL NETWORKSF31NS066638 · NINDS · VANDERBILT UNIVERSITY · PI TURNER, STEPHEN · 2009 to 2010
$47k
NHGRI NIH HHS 1RC2 HG005608-01NHGRI NIH HHS HG004608NHLBI NIH HHS HL065962NHLBI NIH HHS U19 HL065962NIA NIH HHS F30 AG041570NIA NIH HHS F30AG041570NIGMS NIH HHS 5T32GM080178NIGMS NIH HHS T32 GM07347NINDS NIH HHS NS066638-01NLM NIH HHS LM010040
6 · The paper itself

Abstract

backgroundWith the recent decreasing cost of genome sequence data, there has been increasing interest in rare variants and methods to detect their association to disease. We developed BioBin, a flexible collapsing method inspired by biological knowledge that can be used to automate the binning of low frequency variants for association testing. We also built the Library of Knowledge Integration (LOKI), a repository of data assembled from public databases, which contains resources such as: dbSNP and gene Entrez database information from the National Center for Biotechnology (NCBI), pathway information from Gene Ontology (GO), Protein families database (Pfam), Kyoto Encyclopedia of Genes and Genomes (KEGG), Reactome, NetPath - signal transduction pathways, Open Regulatory Annotation Database (ORegAnno), Biological General Repository for Interaction Datasets (BioGrid), Pharmacogenomics Knowledge Base (PharmGKB), Molecular INTeraction database (MINT), and evolutionary conserved regions (ECRs) from UCSC Genome Browser. The novelty of BioBin is access to comprehensive knowledge-guided multi-level binning. For example, bin boundaries can be formed using genomic locations from: functional regions, evolutionary conserved regions, genes, and/or pathways.

methodsWe tested BioBin using simulated data and 1000 Genomes Project low coverage data to test our method with simulated causative variants and a pairwise comparison of rare variant (MAF < 0.03) burden differences between Yoruba individuals (YRI) and individuals of European descent (CEU). Lastly, we analyzed the NHLBI GO Exome Sequencing Project Kabuki dataset, a congenital disorder affecting multiple organs and often intellectual disability, contrasted with Complete Genomics data as controls.

resultsThe results from our simulation studies indicate type I error rate is controlled, however, power falls quickly for small sample sizes using variants with modest effect sizes. Using BioBin, we were able to find simulated variants in genes with less than 20 loci, but found the sensitivity to be much less in large bins. We also highlighted the scale of population stratification between two 1000 Genomes Project data, CEU and YRI populations. Lastly, we were able to apply BioBin to natural biological data from dbGaP and identify an interesting candidate gene for further study.

conclusionsWe have established that BioBin will be a very practical and flexible tool to analyze sequence data and potentially uncover novel associations between low frequency variants and complex disease.

Indexed as

Computational BiologySoftwareAbnormalities, MultipleCase-Control StudiesCaveolin 2Computer SimulationDatabases, GeneticExomeFaceGenetic VariationGenome, HumanGenome-Wide Association StudyGenomicsHematologic DiseasesHumansKruppel-Like Transcription FactorsCAV2 protein, humanCaveolin 2GLI3 protein, humanKruppel-Like Transcription FactorsNerve Tissue ProteinsZinc Finger Protein Gli3

Identifiers

PMID23819467
PMCPMC3654874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.